These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11119807)

  • 21. Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients.
    Gürsoy M; Güvener N; Köksal R; Karavelioğlu D; Baysal C; Ozdemir N; Boyacioğlu S; Bilgin N; Erdal R
    Transplant Proc; 2000 May; 32(3):561-2. PubMed ID: 10812113
    [No Abstract]   [Full Text] [Related]  

  • 22. Posttransplant complications encountered in renal transplantation in the Middle East.
    Al-Khader AA; Shaheen FA
    Transplant Proc; 2004; 36(1):180-3. PubMed ID: 15013340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus prophylaxis in solid organ transplant recipients: the issues.
    Legendre C; Thervet E
    Transplant Proc; 2000 Mar; 32(2):377-8. PubMed ID: 10715444
    [No Abstract]   [Full Text] [Related]  

  • 24. Viral hepatitis elimination: a challenge, but within reach.
    The Lancet
    Lancet; 2022 Jul; 400(10348):251. PubMed ID: 35871799
    [No Abstract]   [Full Text] [Related]  

  • 25. Resolution of hepatitis B viremia in a renal transplant recipient treated with alpha-2b interferon.
    Post AB; Hricik DE; Sterling RK; Bartucci MR; Jacobs GH; Schulak JA
    Nephron; 1998 Aug; 79(4):469-71. PubMed ID: 9689164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis G virus infection in chronic dialysis patients and kidney transplant recipients.
    Fabrizi F; Lunghi G; Bacchini G; Corti M; Guarnori I; Raffaele L; Erba G; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1997 Aug; 12(8):1645-51. PubMed ID: 9269643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of chronic viral hepatitis in children.
    Conjeevaram HS; Di Bisceglie AM
    J Pediatr Gastroenterol Nutr; 1995 May; 20(4):365-75. PubMed ID: 7636678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant alpha-interferon in renal allograft recipients with chronic hepatitis C.
    Ozgür O; Boyacioğlu S; Telatar H; Haberal M
    Nephrol Dial Transplant; 1995 Nov; 10(11):2104-6. PubMed ID: 8643176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Viral Hepatitis in Solid Organ Transplant Recipients.
    Buganza-Torio E; Doucette KE
    Infect Dis Clin North Am; 2018 Sep; 32(3):635-650. PubMed ID: 30146027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of kidney transplant in chronic hepatitis C virus patients: effect of pretransplantation interferon-alpha2b monotherapy.
    González-Roncero F; Gentil MA; Valdivia MA; Algarra G; Pereira P; Toro J; Sayago M; Mateos J
    Transplant Proc; 2003 Aug; 35(5):1745-7. PubMed ID: 12962779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of pretransplant IFN-alpha therapy on interstitial fibrosis in renal allografts with hepatitis C virus infection.
    Ozdemir BH; Ozdemir FN; Sezer S; Haberal M
    Ren Fail; 2007; 29(5):615-22. PubMed ID: 17654326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Novel antiviral agents for the treatment of HCV among renal transplant recipients].
    Fabrizi F; Donato FM; Messa P
    G Ital Nefrol; 2017 Aug; 34(4):35-50. PubMed ID: 28762681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time to act to make elimination of viral hepatitis a reality.
    Kasai T
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):102-103. PubMed ID: 31852633
    [No Abstract]   [Full Text] [Related]  

  • 34. Viral infections in renal transplant recipients: an evolutionary problem.
    Charpentier B
    Adv Nephrol Necker Hosp; 1986; 15():353-78. PubMed ID: 3006452
    [No Abstract]   [Full Text] [Related]  

  • 35. Viral prophylaxis in organ transplant patients.
    Slifkin M; Doron S; Snydman DR
    Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C.
    Huraib S; Iqbal A; Tanimu D; Abdullah A
    Am J Nephrol; 2001; 21(6):435-40. PubMed ID: 11799259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of hepatitis B after renal transplantation: an update.
    Fabrizi F; Lunghi G; Poordad FF; Martin P
    J Nephrol; 2002; 15(2):113-22. PubMed ID: 12018626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultralow-dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients.
    Shu KH; Lan JL; Wu MJ; Cheng CH; Chen CH; Lee WC; Chang HR; Lian JD
    Transplantation; 2004 Jun; 77(12):1894-6. PubMed ID: 15223909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretransplantation alpha-interferon therapy and the effect of hepatitis C virus infection on kidney allograft recipients.
    Gürsoy M; Köksal R; Karavelioğlu D; Colak T; Gür G; Ozdemir N; Boyacioğlu S; Bilgin N
    Transplant Proc; 2000 May; 32(3):580-2. PubMed ID: 10812121
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
    Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
    Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.